Showing results (21-30 of 46) with videos related to

Sort By:
Pageof 5
European Archives of Psychiatry and Clinical Neuroscience|September 15, 2023
Mental health problems during the COVID-19 pandemic among residents of Jimma town: a cross-sectional studyYonas Tesfaye, Bezaye Alemu, Matiwos Soboka, et al.
Frontiers in Psychiatry|January 4, 2021
Loneliness, Social Isolation and Their Difference: A Cross-Diagnostic Study in Persistent Depressive Disorder and Borderline Personality DisorderTabea Nenov-Matt, Barbara B Barton, Julia Dewald-Kaufmann, et al.
European Archives of Psychiatry and Clinical Neuroscience|February 12, 2018
QTc prolongation in short-term treatment of schizophrenia patients: effects of different antipsychotics and genetic factorsIlja Spellmann, Matthias A Reinhard, Diana Veverka, et al.
Scientific Reports|October 24, 2023
Effects of resilience and timing of adverse and adaptive experiences on interpersonal behavior: a transdiagnostic study in a clinical sampleBarbara B Barton, Thomas Ehring, Matthias A Reinhard, et al.
European Archives of Psychiatry and Clinical Neuroscience|July 15, 2026
(Anti)-mattering and its association with child maltreatment and loneliness: evidence from the German versions of the general mattering and anti-mattering scalesMatthias A Reinhard, Djuna Schwedler, Maxime Wendlinger, et al.
Annals of the New York Academy of Sciences|February 5, 2026
Loneliness and Its Associations With Personality Functioning: Evidence From Longitudinal Inpatient Psychotherapy Programs in GermanyJulia I Kunz, Barbara B Barton, Niklas Wolfrum, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|May 12, 2021
Sex differences in pharmacological treatment of major depressive disorder: results from the AMSP pharmacovigilance program from 2001 to 2017Johanna Seifert, Fabienne Führmann, Matthias A Reinhard, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|May 7, 2022
Pharmacological treatment of major depressive disorder according to severity in psychiatric inpatients: results from the AMSP pharmacovigilance program from 2001-2017Johanna Seifert, Hannah B Maier, Fabienne Führmann, et al.
Pageof 5